ArticleNeoplasia (New York, N.Y.)2005

Properties of a telomerase-specific Cre/Lox switch for transcriptionally targeted cancer gene therapy.

Alan E Bilsland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.